Clinical trial NCT01003535 - References

Parkinson´s Disease — Quantification of Cerebral Cholinergic Function in Parkinson´s Disease by Means of Nuclear Medicine Methods

Citation(s)

•   Bucerius J, Joe AY, Schmaljohann J, Gündisch D, Minnerop M, Biersack HJ, Wüllner U, Reinhardt MJ
  Feasibility of 2-deoxy-2-[18F]fluoro-D-glucose- A85380-PET for imaging of human cardiac nicotinic acetylcholine receptors in vivo. Clin Res Cardiol. 2006 Feb;95(2):105-9. Epub 2006 Jan 19. Erratum in: Clin Res Cardiol. 2006 Jun;95(6):354.
•   Ding YS, Fowler JS, Logan J, Wang GJ, Telang F, Garza V, Biegon A, Pareto D, Rooney W, Shea C, Alexoff D, Volkow ND, Vocci F
  6-[18F]Fluoro-A-85380, a new PET tracer for the nicotinic acetylcholine receptor: studies in the human brain and in vivo demonstration of specific binding in white matter. Synapse. 2004 Sep 1;53(3):184-9.
•   Fujita M, Ichise M, van Dyck CH, Zoghbi SS, Tamagnan G, Mukhin AG, Bozkurt A, Seneca N, Tipre D, DeNucci CC, Iida H, Vaupel DB, Horti AG, Koren AO, Kimes AS, London ED, Seibyl JP, Baldwin RM, Innis RB
  Quantification of nicotinic acetylcholine receptors in human brain using [123I]5-I-A-85380 SPET. Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):1620-9. Epub 2003 Oct 2.
•   Fujita M, Ichise M, Zoghbi SS, Liow JS, Ghose S, Vines DC, Sangare J, Lu JQ, Cropley VL, Iida H, Kim KM, Cohen RM, Bara-Jimenez W, Ravina B, Innis RB
  Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease. Ann Neurol. 2006 Jan;59(1):174-7.
•   Fujita M, Seibyl JP, Vaupel DB, Tamagnan G, Early M, Zoghbi SS, Baldwin RM, Horti AG, KoreN AO, Mukhin AG, Khan S, Bozkurt A, Kimes AS, London ED, Innis RB
  Whole-body biodistribution, radiation absorbed dose, and brain SPET imaging with [123i]5-i-A-85380 in healthy human subjects. Eur J Nucl Med Mol Imaging. 2002 Feb;29(2):183-90.
•   Fukuyama H
  Functional brain imaging in Parkinson's disease-overview. J Neurol. 2004 Oct;251 Suppl 7:vII1-3. Review.
•   Mamede M, Ishizu K, Ueda M, Mukai T, Iida Y, Fukuyama H, Saga T, Saji H
  Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT. J Nucl Med. 2004 Sep;45(9):1458-70.
•   Obrzut SL, Koren AO, Mandelkern MA, Brody AL, Hoh CK, London ED
  Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies. Nucl Med Biol. 2005 Nov;32(8):869-74.

Quantification of Cerebral Cholinergic Function in Patients With Parkinson´s Disease by Means of Nuclear Medicine Methods

Details for clinical trial NCT01003535